ONCE-DAILY CO-ADMINISTRATION OF GLYCOPYRRONIUM AND INDACATEROL IMPROVES LUNG FUNCTION AND SYMPTOMS IN PATIENTS WITH COPD VERSUS INDACATEROL ALONE: THE GLOW6 STUDY

被引：0
|
作者：
Vincken, W. [1 ]
Goyal, P. [2 ]
Jack, D. [3 ]
Henley, M. [4 ]
Mcbryan, D. [4 ]
机构：
[1] Univ Brussels, Univ Hosp Brussels, Div Resp, Brussels, Belgium
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Horsham Res Ctr, Horsham, W Sussex, England
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] ONCE-DAILY CO-ADMINISTRATION OF GLYCOPYRRONIUM AND INDACATEROL VIA BREEZHALER® DEVICE IMPROVES LUNG FUNCTION AND SYMPTOMS IN PATIENTS WITH COPD VERSUS INDACATEROL ALONE: THE GLOW6 STUDY
    Vincken, W.
    Aumann, J.
    Jack, D.
    Chen, H.
    Henley, M.
    Goyal, P.
    THORAX, 2013, 68 : A181 - A182
  • [2] CO-ADMINISTRATION OF GLYCOPYRRONIUM AND INDACATEROL IMPROVES LUNG FUNCTION AND SYMPTOMS IN PATIENTS WITH COPD VERSUS INDACATEROL ALONE: THE GLOW6 STUDY
    Walter, Vincken
    Goyal, Pankaj
    Jack, Damon
    Chen, Hungta
    Henley, Michelle
    Mcbryan, Danny
    RESPIROLOGY, 2013, 18 : 30 - 30
  • [3] Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
    Vincken, Walter
    Aumann, Joseph
    Chen, Hungta
    Henley, Michelle
    McBryan, Danny
    Goyal, Pankaj
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 215 - 228
  • [4] Free triple combination of glycopyrronium, indacaterol and ICS improves lung function and dyspnoea versus free double combination of indacaterol and ICS in patients with COPD: A post-hoc analysis from the GLOW6 study
    Vincken, Walter
    Aumann, Joseph
    Goya, Pankaj
    Altman, Pablo
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [5] Combining Once-Daily Bronchodilators In COPD: Indacaterol Plus Tiotropium Versus Tiotropium Alone
    Mahler, D. A.
    D'Urzo, A.
    Peckitt, C.
    Lassen, C.
    Kramer, B.
    Filcek, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [6] Improvement In Lung Function With Twice-Daily Indacaterol/glycopyrrolate Versus Once-Daily Indacaterol In Patients With Moderate-To-Severe COPD: Results From The Flight3 Study
    Mahler, D. A.
    Ferguson, G. T.
    Fucile, S.
    Yadao, A.
    Wang, Q.
    Ayers, T.
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] ONCE-DAILY GLYCOPYRRONIUM IMPROVES LUNG FUNCTION IN COPD PATIENTS: POOLED RESULTS OF THE GLOW1 AND GLOW2 STUDIES
    Banerji, D.
    Alagappan, V.
    Martin, C.
    He, E.
    Chen, H.
    Overend, T.
    THORAX, 2012, 67 : A26 - A26
  • [8] Pulmonary Dementia with Indacaterol / Glycopyrronium improves the cardiac Function of COPD Patients: the CLAIM Study
    Hohlfeld, Jens M.
    Vogel-Claussen, Jens
    Biller, Heike
    Berliner, Dominik
    Berschneider, Korbinian
    Tillmann, Hanns-Christian
    Hiltl, Simone
    Bauersachs, Johann
    Welte, Tobias
    INTERNIST, 2018, 59 : S50 - S51
  • [9] Once-Daily Qva149 Provides Clinically Meaningful Improvements In Lung Function And Clinical Outcomes Versus Placebo, Indacaterol, Glycopyrronium, Tiotropium And Salmeterol/fluticasone In Patients With COPD
    Vogelmeier, C.
    Dahl, R.
    D'Urzo, T.
    Chen, H.
    Green, Y.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] EFFECTIVENESS OF ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) WITH OTHER COMBINATIONS OF INHALED MAINTENANCE THERAPIES FOR COPD: THE LUMIERE STUDY DESIGN
    Price, D.
    Mezzi, K.
    Roche, N.
    Decuypere, L.
    Molimard, M.
    Grouin, J. M.
    Altman, P.
    RESPIROLOGY, 2016, 21 : 188 - 188
12345